LRMR
Larimar Therapeutics Inc.
$3.62
-$0.29(-7.42%)
41
Overall
--
Value
54
Tech
28
Quality
Market Cap
$331.23M
Volume
1.40M
52W Range
$1.61 - $9.50
Target Price
$19.50
Key Metrics Overview
| Market Cap | $331.23M | P/E Ratio | N/A |
| 52W High | $9.50 | 52W Low | $1.61 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | 18.2% | 52W Position | 25.5% |
| Overall Score | 41 | Value Score | -- |
| Quality Score | 28 | Technical Score | 54 |
Growth Analysis
| EPS Current Est | $-1.66 | EPS Next Est | $-1.61 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LRMR | $3.62 | -7.4% | 1.40M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Larimar Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW